Fusion Family Wealth LLC Gilead Sciences, Inc. Transaction History

Fusion Family Wealth LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$62.53 - $70.05 $13,256 - $14,850	-212 Closed	0 $0
Q4 2018 Jan 18, 2019	BUY	$60.54 - $79.0 $60 - $79	1 Added 0.47%	212 $13,000
Q3 2018 Nov 07, 2018	BUY	$71.28 - $78.92 $213 - $236	3 Added 1.44%	211 $16,000
Q2 2018 Aug 03, 2018	BUY	$64.88 - $75.68 $64 - $75	1 Added 0.48%	208 $15,000
Q1 2018 May 02, 2018	BUY	$72.84 - $88.8 $145 - $177	2 Added 0.98%	207 $16,000
Q4 2017 Feb 06, 2018	BUY	$71.15 - $83.52 $14,585 - $17,121	205 New	205 $15,000
Q3 2017 Oct 30, 2017	SELL	$72.11 - $85.47 $14,638 - $17,350	-203 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	203	203 $14,000

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Fusion Family Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Fusion Family Wealth LLC with notifications on news.